Trials / Conditions / Pancreatic Insulinoma
Pancreatic Insulinoma
4 registered clinical trials studyying Pancreatic Insulinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT) NCT05735912 | Azienda Ospedaliera Universitaria Integrata Verona | N/A |
| Withdrawn | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine NCT02831179 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Completed | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade N NCT01204476 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer NCT00454363 | National Cancer Institute (NCI) | Phase 2 |